FDA Brief

Company record

Imprimis NJOF, LLC

0 FDA warning letters since 2023 and 4 recalls in the last 12 months.

Get an email the day FDA posts anything new about Imprimis NJOF, LLC.

Recalls

ReportedClassFirmProduct and reason
Jan 14 Class II Imprimis NJOF, LLC
Drug
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Presence of particulate matter - Glass like particles.
FDA notice D-0251-2026
Jan 14 Class II Imprimis NJOF, LLC
Drug
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
Presence of particulate matter - Glass like particles.
FDA notice D-0250-2026
Jan 14 Class II Imprimis NJOF, LLC
Drug
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Presence of particulate matter - Glass like particles.
FDA notice D-0249-2026
Nov 26, 2025 Class III Imprimis NJOF, LLC
Drug
Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852,…
Subpotent Drug
FDA notice D-0157-2026